Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $221.68 | 10 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $148.56 | 6 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $56.79 | 3 | $0 (2024) |
| Genentech USA, Inc. | $16.33 | 1 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $147.79 | 6 | ABBVIE INC. ($105.21) |
| 2022 | $43.35 | 2 | ABBVIE INC. ($43.35) |
| 2021 | $30.54 | 2 | Genentech USA, Inc. ($16.33) |
All Payment Transactions
10 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/25/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $28.34 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/16/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: ANTI-INFECTIVE | ||||||
| 09/03/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $21.80 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/22/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $30.04 | General |
| Category: ANTI-INFECTIVE | ||||||
| 06/27/2024 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.39 | General |
| Category: ANTI-INFECTIVE | ||||||
| 04/11/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $20.78 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 12/10/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $24.11 | General |
| Category: ANTI-INFECTIVE | ||||||
| 08/11/2022 | ABBVIE INC. | DALVANCE (Drug) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: ANTI-INFECTIVE | ||||||
| 11/17/2021 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.21 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 01/19/2021 | Genentech USA, Inc. | Xofluza (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: Virology & Specialty Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 9 | 660 | 681 | $683,732 | $95,965 |
| 2022 | 13 | 1,090 | 1,170 | $555,628 | $137,134 |
| 2021 | 14 | 1,997 | 2,262 | $472,818 | $201,887 |
| 2020 | 9 | 638 | 660 | $129,861 | $56,678 |
All Medicare Procedures & Services
45 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99285 | Emergency department visit with high level of medical decision making | Facility | 2023 | 305 | 320 | $469,440 | $55,292 | 11.8% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 48 | 49 | $92,316 | $10,423 | 11.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 79 | 82 | $20,608 | $8,741 | 42.4% |
| 99284 | Emergency department visit with moderate level of medical decision making | Facility | 2023 | 70 | 70 | $69,720 | $7,399 | 10.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 62 | $10,622 | $5,072 | 47.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $8,957 | $3,132 | 35.0% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2023 | 19 | 19 | $4,750 | $2,656 | 55.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 17 | 17 | $4,394 | $1,668 | 38.0% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 39 | 39 | $2,925 | $1,581 | 54.1% |
| 99285 | Emergency department visit for life threatening or functioning severity | Facility | 2022 | 204 | 214 | $313,938 | $43,904 | 14.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 242 | 277 | $47,456 | $27,285 | 57.5% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 105 | 105 | $27,030 | $13,273 | 49.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 100 | 105 | $26,389 | $12,205 | 46.3% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2022 | 256 | 285 | $21,375 | $11,661 | 54.6% |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | Office | 2022 | 17 | 17 | $12,300 | $9,519 | 77.4% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 27 | 27 | $50,868 | $6,638 | 13.0% |
| 99284 | Emergency department visit for problem of high severity | Facility | 2022 | 39 | 39 | $38,844 | $4,826 | 12.4% |
| 87637 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19), influenza virus types a and b, and respiratory syncytial virus | Office | 2022 | 28 | 28 | $6,895 | $3,914 | 56.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 20 | 20 | $7,789 | $3,119 | 40.0% |
| 87428 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus and influenza | Office | 2022 | 18 | 18 | $1,800 | $547.62 | 30.4% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2022 | 13 | 14 | $420.00 | $198.38 | 47.2% |
| 81003 | Automated urinalysis test | Office | 2022 | 21 | 21 | $525.00 | $44.97 | 8.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 477 | 479 | $123,344 | $63,610 | 51.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 446 | 590 | $102,909 | $63,224 | 61.4% |
| 87811 | Sars-cov-2 covid19 w/optic | Office | 2021 | 591 | 700 | $52,500 | $28,966 | 55.2% |
About Dr. Robert Levy, MD
Dr. Robert Levy, MD is a Emergency Medicine healthcare provider based in Stony Brook, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/21/2006. The National Provider Identifier (NPI) number assigned to this provider is 1568561108.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Robert Levy, MD has received a total of $221.68 in payments from pharmaceutical and medical device companies, with $147.79 received in 2024. These payments were reported across 10 transactions from 3 companies. The most common payment nature is "Food and Beverage" ($221.68).
As a Medicare-enrolled provider, Levy has provided services to 4,385 Medicare beneficiaries, totaling 4,773 services with total Medicare billing of $491,665. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.
Practice Information
- Specialty Emergency Medicine
- Location Stony Brook, NY
- Active Since 09/21/2006
- Last Updated 02/11/2020
- Taxonomy Code 207P00000X
- Entity Type Individual
- NPI Number 1568561108
Products in Payments
- DALVANCE (Drug) $148.56
- XARELTO (Drug) $56.79
- Xofluza (Drug) $16.33
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Emergency Medicine Doctors in Stony Brook
Dr. Adam Singer, M.d, M.D
Emergency Medicine — Payments: $675,767
Paul Taglienti, Md, MD
Emergency Medicine — Payments: $1,924
Dr. Jose Torres, Md, MD
Emergency Medicine — Payments: $1,565
Dr. Lawrence Schiff, Md, MD
Emergency Medicine — Payments: $1,071
Dr. Joseph Corcoran, Md, MD
Emergency Medicine — Payments: $813.09
Dr. Sayed Khwaja, D.o, D.O
Emergency Medicine — Payments: $612.51